	Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC). BJU Int Pasanen N, Talala K, Remmers S, Tammela TLJ, Hugosson J, Godtman RA, Taari K, Bangma C, Hond ED, Nelen V, Wyler S, Kwiatkowski M, Puliti D, Gorini G, Gonzàlez L, Lujan M, Roobol MJ, Auvinen A. PMID: 42400346 [PubMed - as supplied by publisher]
	Competing Mortality Redefines the Net Benefit of Additional Surgery After Endoscopic Resection for T1 Colorectal Cancer in Older Adults. Dig Endosc Ichimasa K, Kudo SE, Kouyama Y, Okumura T, Maeda Y, Hayashi T, Yeoh KG, Miyachi H, Misawa M. PMID: 42400343 [PubMed - indexed for MEDLINE]
	The dual role of lectins in cancer-immunotherapy tools and therapeutic targets. FEBS Lett Dziewicka M, Graczyk-Jarzynka A. PMID: 42400321 [PubMed - as supplied by publisher]
	Genome-Wide Association Study of Nevus Count Reveals Opposing Effects of Genetic Loci Near IRF4 and MC1R on Flat Versus Raised Nevus Count in the Brisbane Twin Nevus Study: A Cross-Sectional Analysis. Pigment Cell Melanoma Res Ingold N, Zhu G, Duffy DL, Mothershaw A, Martin NG, MacGregor S, Law MH. PMID: 42400230 [PubMed - indexed for MEDLINE]
	Impact of Operative Time on Postoperative Severe Complications in Elderly Patients With Colorectal Cancer: A Multicenter Retrospective Study. Asian J Endosc Surg Yamashita M, Hashimoto S, Tominaga T, Takamura Y, Katayama H, Noda K, Tei S, Ono R, Hisanaga M, Oishi K, Fukuoka H, Uchida F, Shiraishi T, Kunizaki M, Nonaka T, Matsumoto K. PMID: 42400183 [PubMed - indexed for MEDLINE]
	Sex Hormone Receptors, HBV Integrations and Their Prognostic Predictive Value Among Hepatocellular Carcinoma Patients. Int J Cancer He D, Zeng X, Yin L, Liu Y, Zhou W, Liu X, Zhao L. PMID: 42400106 [PubMed - as supplied by publisher]
	Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence. Biomark Res Heydari F, Zendehdel H, Varkiani MM, Fahmi S, Derakhshani M, Anvari S, Farhid F, Hamblin MR, Naghinezhad J. PMID: 42400102 [PubMed - as supplied by publisher]
	Telomerase as a therapeutic Bullseye: advances in cancer treatment and clinical trials : A comprehensive review of small molecule inhibitors, antisense oligonucleotides, and immunotherapeutic strategies targeting the telomerase catalytic subunit (hTERT). Biol Res Hussain A, Abbas M, Long M, Mustafa G, Yasir HM, Abbas T, Raza Y, Lateef M, Shoaib M, Ul Abideen Z, Shah W. PMID: 42400091 [PubMed - as supplied by publisher]
	Emerging artificial intelligence advances in oncology: latest updates from the 2026 AACR annual meeting. J Hematol Oncol Li YR, Shao Z, Nan H. PMID: 42400083 [PubMed - indexed for MEDLINE]
	Cardiovascular event burden in women with breast cancer treated with CDK4/6 inhibitors: a retrospective matched cohort study. Cardiooncology Leenaerts V, Cauwenberghs N, Wildiers H, Neven P, Kuznetsova T, Van Aelst L. PMID: 42400066 [PubMed - as supplied by publisher]
	Perioperative prediction of adnexal malignancy by an interpretable machine learning model for guiding ovarian preservation in premenopausal endometrial cancer. J Ovarian Res Wang J, Ding J, Wang F, Wang YX, Gu J, Li XM. PMID: 42400061 [PubMed - as supplied by publisher]
	The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance. J Transl Med Wang Z, Li T, Li K. PMID: 42400056 [PubMed - as supplied by publisher]
	Longitudinal evaluation of tumor-infiltrating lymphocyte scoring using automated region of interest registration in breast cancer. Breast Cancer Res Fiorin A, Adalid-Llansa L, Reverté L, Sauras-Colón E, Gallardo-Borràs N, Rashwan HA, Bosch-Príncep R, Fischer-Carles A, Goyda E, Lejeune M, Mata-Cano D, Puig D, Sánchez-Alcántara T, Relloso Ortiz de Uriarte M, Llobera-Serentill M, Izuel-Navarro JA, López-Pablo C. PMID: 42400054 [PubMed - as supplied by publisher]
	Fear of Cancer Recurrence and Coping in Young Breast Cancer Survivors: A Secondary Analysis. Cancer Med Torrisi C, Hays ME, Li Y, Johns SA. PMID: 42400053 [PubMed - indexed for MEDLINE]
	Decoding the dynamic extracellular matrix in cancer-3D models and bioscaffolds rewire the rules of tumor progression. FEBS Lett Mangani S, Spanopoulos K, Piperigkou Z, Karamanos NK. PMID: 42400051 [PubMed - as supplied by publisher]
	The burden of ovarian cancer attributable to occupational asbestos exposure in Asia from 1990 to 2021: an analysis of the global burden of disease study 2021. Trop Med Health Yu Y, Zhang W, Deng T, Li N, Wu J. PMID: 42400040 [PubMed - as supplied by publisher]
	Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives. Mol Cancer Vatankhah A, Hoseinzadeh Moghaddam S, Rahmanian M, Khosropanah S, Oroojalian F, Kesharwani P, Sahebkar A. PMID: 42400029 [PubMed - as supplied by publisher]
	Targeting tumor-associated bacteria in digestive system cancers: carcinogenic mechanisms and nano-regulate platform design. J Nanobiotechnology Liu H, Wang X, Xi QI, Li T, Huang H, Zhao J, Guan L, Liu F. PMID: 42399994 [PubMed - as supplied by publisher]
	Prognostic value of surgical margin and margin to depth of invasion ratio in oral squamous cell carcinoma: a meta-analysis. BMC Oral Health Xu J, Cui Q, Chen Y, Yu W, Xu Y, Shao Y, Liu Z, Chen Z. PMID: 42399960 [PubMed - as supplied by publisher]
	Persistent NET states link lesion-related microbial signals to the cold tumor-related local restrictive environment: a context-dependent working model. Cell Commun Signal Meng F, Wong Z, Chen J, Zhang Z, Deng Z, Tian X. PMID: 42399946 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1952297

Page 1 of 97615



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy